


for 9




selling bcrx was a mistake, it was stupid. it's probably going to 8 in a couple of days. granted, it could go down, and the fundamentals are mediocre. well, OK, but it's an interesting drug portfolio with interesting partners. even 8 is silly. the first real resistance is at 11.


the news is they presented at a conference in Switzerland today
earlier